AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 108 filers reported holding AVROBIO INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $167,000 | -11.6% | 29,911 | +40.7% | 0.00% | -100.0% |
| Q2 2021 | $189,000 | -83.6% | 21,255 | -76.6% | 0.00% | -85.7% |
| Q1 2021 | $1,152,000 | +176.9% | 90,747 | +204.3% | 0.01% | +133.3% |
| Q4 2020 | $416,000 | -32.4% | 29,825 | -36.9% | 0.00% | -62.5% |
| Q3 2020 | $615,000 | -52.5% | 47,233 | -36.3% | 0.01% | -61.9% |
| Q2 2020 | $1,294,000 | +237.9% | 74,176 | +201.5% | 0.02% | +110.0% |
| Q1 2020 | $383,000 | -62.1% | 24,605 | -51.0% | 0.01% | +66.7% |
| Q4 2019 | $1,010,000 | +150.6% | 50,195 | +75.9% | 0.01% | +50.0% |
| Q3 2019 | $403,000 | +122.7% | 28,541 | +162.6% | 0.00% | +100.0% |
| Q4 2018 | $181,000 | – | 10,870 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |